Please note: The information displayed on this page might be outdated.
Paradigm BioPharma: Launching Ph 3 in 2020 in OA pts w/bone marrow edema lesions (BML). Positive Ph2b results in subjects w/OA & BML - stat sig improvement on pain reduction & BML volume/grade reductions on MRI. Q12020: initial data from compassionate use trial (ex-NFL subjects w/OA) and joint IND submission to FDA/EMA for pivotal trial in Mucopolysaccharidosis. 500+ pts treated to date. Exp AUS rev-gen in Q3 20.
Based in...
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Public, USA
Market Cap
500MM - 1B
517 Finders Lane
Melbourne, VIC 3000

Company Participants at Solebury Trout Virtual Global Healthcare Conference Series

  • Paul Rennie, Chief Executive Officer

Top 10 Holders of Paradigm Biopharmaceuticals Ltd.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RBC Global Asset Management (Asia) Ltd. 4.58 8,823,815 19.50 Funds 7/31/20
The Vanguard Group, Inc. 2.32 4,468,821 9.88 Funds 8/31/20
Vanguard Investments Australia Ltd. 1.11 2,144,515 4.74 Funds 8/31/20
Allianz Global Investors Asia Pacific Ltd. 0.91 1,756,212 3.88 Funds 5/31/20
Perennial Value Management Ltd. 0.77 1,492,100 3.30 Stakes 8/17/20
RAM Active Investments SA 0.07 164,866 0.36 Funds 12/31/19
Smith & Williamson Investment Management LLP 0.08 145,000 0.32 Funds 7/31/20
Adepa Asset Management SA 0.05 115,000 0.25 Funds 12/31/19
Allianz Global Investors GmbH 0.02 44,578 0.10 Funds 7/31/20
Allianz Global Investors U.S. LLC 0.01 18,271 0.04 Funds 7/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.